Northwest Biotherapeutics Inc (NWBO) stock
NWBOOTCPharmaceutical PreparationsFiscal year ends December 31
$0.16−0.00 (-0.88%)
Close on Oct 19, 2026Market cap $254.79MP/E –Yield –
Northwest Biotherapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Northwest Biotherapeutics's revenue for the twelve months ending Jun 30, 2026 was $2.17M, up 98.6% year over year. For fiscal 2025 it was $1.38M, down 0.3% from the year before. Over ten years it grew -2.3% a year on average. The highest annual figure on record is $2.41M in fiscal 2019.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.38M | -0.3% |
| FY2024 | Dec 31, 2024 | $1.38M | -28.5% |
| FY2023 | Dec 31, 2023 | $1.93M | +14.8% |
| FY2022 | Dec 31, 2022 | $1.68M | +67.5% |
| FY2021 | Dec 31, 2021 | $1.01M | -22.2% |
| FY2020 | Dec 31, 2020 | $1.29M | -46.4% |
| FY2019 | Dec 31, 2019 | $2.41M | +485.0% |
| FY2018 | Dec 31, 2018 | $412.00K | +22.6% |
| FY2017 | Dec 31, 2017 | $336.00K | -46.1% |
| FY2016 | Dec 31, 2016 | $623.00K | -64.2% |
| FY2015 | Dec 31, 2015 | $1.74M | +19.6% |
| FY2014 | Dec 31, 2014 | $1.45M | +79.7% |
| FY2013 | Dec 31, 2013 | $809.00K | +4.8% |
| FY2012 | Dec 31, 2012 | $772.00K | +7620.0% |
| FY2011 | Dec 31, 2011 | $10.00K | 0.0% |
| FY2010 | Dec 31, 2010 | $10.00K | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $807.00K | +516.0% |
| Q1 FY2026 | Mar 31, 2026 | $494.00K | +31.7% |
| Q4 FY2025 | Dec 31, 2025 | $672.00K | +190.9% |
| Q3 FY2025 | Sep 30, 2025 | $200.00K | -44.0% |
| Q2 FY2025 | Jun 30, 2025 | $131.00K | -74.3% |
| Q1 FY2025 | Mar 31, 2025 | $375.00K | +32.0% |
| Q4 FY2024 | Dec 31, 2024 | $231.00K | -48.1% |
| Q3 FY2024 | Sep 30, 2024 | $357.00K | -12.1% |
| Q2 FY2024 | Jun 30, 2024 | $510.00K | +153.7% |
| Q1 FY2024 | Mar 31, 2024 | $284.00K | -67.7% |
| Q4 FY2023 | Dec 31, 2023 | $445.00K | -25.5% |
| Q3 FY2023 | Sep 30, 2023 | $406.00K | +97.1% |
| Q2 FY2023 | Jun 30, 2023 | $201.00K | -57.9% |
| Q1 FY2023 | Mar 31, 2023 | $880.00K | +118.4% |
| Q4 FY2022 | Dec 31, 2022 | $597.00K | – |
| Q3 FY2022 | Sep 30, 2022 | $206.00K | -41.1% |
| Q2 FY2022 | Jun 30, 2022 | $477.00K | -5.2% |
| Q1 FY2022 | Mar 31, 2022 | $403.00K | +86.6% |
| Q4 FY2021 | Dec 31, 2021 | $0 | -100.0% |
| Q3 FY2021 | Sep 30, 2021 | $350.00K | -38.6% |
| Q4 FY2020 | Dec 31, 2020 | $503.00K | -43.9% |
| Q3 FY2020 | Sep 30, 2020 | $216.00K | -63.6% |
| Q2 FY2020 | Jun 30, 2020 | $2.00K | -99.7% |
| Q1 FY2020 | Mar 31, 2020 | $570.00K | +68.1% |
| Q4 FY2019 | Dec 31, 2019 | $897.00K | +98.0% |
| Q3 FY2019 | Sep 30, 2019 | $593.00K | +113.3% |
| Q2 FY2019 | Jun 30, 2019 | $581.00K | +340.2% |
| Q1 FY2019 | Mar 31, 2019 | $339.00K | +959.4% |
| Q3 FY2018 | Sep 30, 2018 | $453.00K | +538.0% |
| Q2 FY2018 | Jun 30, 2018 | $278.00K | +74.8% |
| Q1 FY2018 | Mar 31, 2018 | $132.00K | -15.9% |
| Q4 FY2017 | Dec 31, 2017 | $32.00K | -86.4% |
| Q4 FY2016 | Dec 31, 2016 | $71.00K | -91.8% |
| Q3 FY2016 | Sep 30, 2016 | $159.00K | – |
| Q2 FY2016 | Jun 30, 2016 | $157.00K | – |
| Q1 FY2016 | Mar 31, 2016 | $236.00K | – |
| Q4 FY2015 | Dec 31, 2015 | $863.00K | – |
See a number that looks wrong?